Alterations of ERK gene and the signal transduction pathway in oral squamous cell carcinoma and the roles in the genesis of the cancer

口腔鳞癌中ERK基因及信号转导通路的改变及其在癌症发生中的作用

基本信息

  • 批准号:
    12470381
  • 负责人:
  • 金额:
    $ 9.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

This grant research was aimed to find abnormalities of signal transduction pathway of ERK2 in oral cancers, and to elucidate roles of the signals in the genesis of this cancer. Results obtained were(1) by CGH analyzes we found that 3 oral squamous cell carcinoma(OSCC) cell lines had the 1.7 Mb commonly amplified region al chr. 22 q11.2.-12, where ERK2 is mapped. Overexpression of ERK mRNA was detected in the 2 cell lines. Interestingly, there was no overlapping in ERK overexpression , ras mutation and EGFR amplification in 15 but one cell line, being consistent with that these proteins work in the same pathway from EGF to ERK.(2) The aberrant growth signal transduction from EGF to ERK or from EGF to AKT was found in 2/10(20%) or 3/5(60%), respectively, cell lines, suggesting the frequent abnormal signal transduction.(3) 5 Genes for proteins which were first shown to interact with ERK2 were isolated, including one new gene. One of the known protein, Naf1(HIV Nef associated factor) was found to be localized in the cytoplasm, phosphorylated by ERK, and suppressed the translocation of ERK to the nuclei. Further Naf1 phosphorylation was important in binding to HIV Nef.(4) in colorectal cancer tissues overexpression of ERK or H-ras was.closely related to cases with distant metastasis. Further coordinate activation of signal proteins from EGFR to ERK were observed in cancer tissues but not in the adjacent normal tissue, suggesting the importance of this pathway in vivo.(5) an MEK inhibitor (U0126) suppressed the growth of high ERK-expressor more efficiently than high EGFR-expressor.
本研究旨在发现ERK2信号转导通路在口腔癌中的异常,并阐明其在口腔癌发生中的作用。结果表明:(1)CGH分析发现,3株口腔鳞状细胞癌(OSCC)细胞系均有1.7Mb共同扩增区al-Chr。22 q11.2.-12,其中定位了ERK2。ERK基因在两种细胞系中均有高表达。有趣的是,在15个细胞株中,ERK的过度表达、ras突变和EGFR扩增没有重叠,这与这些蛋白从EGF到ERK的作用途径是一致的。(2)分别有2/10(20%)和3/5(60%)的细胞株发现EGF到ERK和EGF到AKT的异常生长信号转导,表明信号转导频繁。(3)首次发现与ERK2相互作用的蛋白的5个基因,其中包括1个新基因。已知的蛋白之一,Naf1(HIV Nef相关因子)被发现定位于细胞质中,被ERK磷酸化,并抑制ERK到细胞核的转位。在结直肠癌组织中,ERK或H-ras的过度表达与远处转移密切相关。在癌组织中观察到从EGFR到ERK的信号蛋白的进一步协同激活,而在邻近的正常组织中则没有,这表明这一途径在体内的重要性。(5)MEK抑制剂(U0126)比EGFR高表达基因更有效地抑制ERK高表达基因的生长。

项目成果

期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Krishnamurthy J, Kannan K, Feng J, Mohanprasad BK, Tsuchida N, Shanmugam G.: "The tumor suppressor gene ING1 in Indian oral squamous cell carcinoma"Oral Oncol.. 37(3). 222-224 (2001)
Krishnamurthy J、Kannan K、Feng J、Mohanprasad BK、Tsuchida N、Shanmugam G.:“印度口腔鳞状细胞癌中的抑癌基因 ING1”Oral Oncol.. 37(3)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
土田信夫,中島琢磨 他: "DNAダメージによるp53蛋白質の癌抑制のシグナルとヒト癌における遺伝子変異。"蛋白質・核酸・酵素. 45. 1742-1751
Nobuo Tsuchida、Takuma Nakajima 等人:“人类癌症中 DNA 损伤和基因突变诱导的 p53 蛋白的癌症抑制信号。”45。1742-1751
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
GOCF, Tsuchida N, Nakajima T, 他: "Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis"Exp Cell Res. 265・1. 145-151 (2001)
GOCF、Tsuchida N、Nakajima T 等人:“p53 诱导的细胞凋亡中细胞色素 c 的半胱天冬酶依赖性胞质释放和 Bax 的膜易位”Exp Cell Res 265·1(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
5 ; Krishnamurthy J, Kannan K, Feng J, Mohanprasad BK, Tsuchida N, Shanmugam G.: "Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma"Oral Oncology. 37・3. 222-224 (2001)
5;Krishnamurthy J、Kannan K、Feng J、Mohanprasad BK、Tsuchida N、Shanmugam G.:“印度口腔鳞状细胞癌候选肿瘤抑制基因 ING1 的突变分析”口腔肿瘤学 37·3。 )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsumura K, Iritani A, Enomoto S, Tsuchida N, 他: "Defining a common region of DNA amplification at 22q11.2-12 in head and neck squamous cell carcinomas by quantitative FISH analysis"Genes Chromosomes Cancer. 29・3. 207-212 (2000)
Matsumura K、Iritani A、Enomoto S、Tsuchida N 等人:“通过定量 FISH 分析定义头颈鳞状细胞癌 22q11.2-12 处 DNA 扩增的常见区域”基因染色体癌症。 207-212(2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUCHIDA Nobuo其他文献

TSUCHIDA Nobuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUCHIDA Nobuo', 18)}}的其他基金

Abnormalities of structure, function, expression, and signal transduction of ERK in relation to carcinogenesis
ERK结构、功能、表达和信号转导异常与癌变相关
  • 批准号:
    16390520
  • 财政年份:
    2004
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Aberrant cell growth signaling in oral cancer
口腔癌中的异常细胞生长信号
  • 批准号:
    14370579
  • 财政年份:
    2002
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Genetic alterations in cancers of digestive tract as analyzed by CGH, in relation to genesis of cancer and the metastasis.
通过 CGH 分析消化道癌症的遗传改变与癌症发生和转移的关系。
  • 批准号:
    10670492
  • 财政年份:
    1998
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Roles of p53 and ras gene mutations in genesis of oral SCC in India
p53 和 ras 基因突变在印度口腔鳞状细胞癌发生中的作用
  • 批准号:
    06044072
  • 财政年份:
    1994
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Molecular diagnosis of oral cancer based on aberrant expression and structural alterations of the p53 tumor suppressor gene
基于p53抑癌基因异常表达和结构改变的口腔癌分子诊断
  • 批准号:
    03557075
  • 财政年份:
    1991
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Analysis of oncogenes and tumor-suppressor genes in oral cancers and the application to diagnosis
口腔癌癌基因和抑癌基因分析及其在诊断中的应用
  • 批准号:
    01440075
  • 财政年份:
    1989
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
In vitro differentiation of human osteosarcoma cells
人骨肉瘤细胞的体外分化
  • 批准号:
    62480374
  • 财政年份:
    1987
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
  • 批准号:
    10991546
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
Detection of novel therapeutic targets and biomarkers via identification of beneficial oral/ gut bacteria to enhance the response of PD1/PD-L1 blockade therapy in oral cancer patients
通过鉴定有益的口腔/肠道细菌来检测新的治疗靶点和生物标志物,以增强口腔癌患者 PD1/PD-L1 阻断疗法的反应
  • 批准号:
    24K13070
  • 财政年份:
    2024
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Application of IL-1RA to the sensitizing and mucositis-preventive effects of oral cancer radiotherapy.
IL-1RA在口腔癌放疗增敏和预防粘膜炎中的应用。
  • 批准号:
    23K08931
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of carcinomatous bone pain in oral cancer focusing on mct4 and development of new therapeutic agents
以MCT4为中心阐明口腔癌癌性骨痛机制并开发新治疗药物
  • 批准号:
    23K16147
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
  • 批准号:
    10760626
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
  • 批准号:
    10805177
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
Novel molecular mechanism of oral cancer pain focused attention on plastic changes in intercellular network in the trigeminal ganglion
口腔癌疼痛的新分子机制关注三叉神经节细胞间网络的可塑性变化
  • 批准号:
    23H03108
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of IQGAPs, a small GTPase target protein, in the regulation of oral cancer progression
IQGAP(一种小 GTP 酶靶蛋白)在调节口腔癌进展中的作用
  • 批准号:
    23K09145
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proposal of a high-throughput 3D culture system and novel resistance mechanisms of oral cancer
口腔癌高通量3D培养系统和新型耐药机制的提出
  • 批准号:
    23K09317
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the development of antibody-drug conjugate orphan drugs based on photodynamic therapy targeting oral cancer.
基于口腔癌光动力疗法的抗体药物偶联孤儿药的开发研究。
  • 批准号:
    23K09344
  • 财政年份:
    2023
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了